Menopausal hormonal therapy or non-hormonal treatment: rational choice

Patients with the "climacteric syndrome" diagnosis make only 1,0% in structure of the general incidence of the women who visit the female consultation, and 1.6% - total of the patients consisting on the dispensary account. The patients who are health workers ask for medical care less than...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: T Yu Pestrikova, E A Yurasova, T V Yachinskaya, T D Kovalyova
التنسيق: مقال
اللغة:Russian
منشور في: IP Berlin A.V. 2015-06-01
سلاسل:Гинекология
الموضوعات:
الوصول للمادة أونلاين:https://gynecology.orscience.ru/2079-5831/article/viewFile/28441/pdf
الوصف
الملخص:Patients with the "climacteric syndrome" diagnosis make only 1,0% in structure of the general incidence of the women who visit the female consultation, and 1.6% - total of the patients consisting on the dispensary account. The patients who are health workers ask for medical care less than managers, teachers. Patients with the diagnosis of a climacteric syndrome had a certain relation to reception of the menopausal hormonal therapy (MHT). So, 22.69% of patients initially feel fear of reception of hormonal preparations; 16.81% - pass to reception of MHT after absence of effect from reception of non-hormonal therapy. Only 16.81% of patients have contraindications to reception of MHT.Purpose of MHT (a combination of estradiol to 1 mg / drospirenone 2 mg) renders high medical effect at patients with a climacteric syndrome (p
تدمد:2079-5696
2079-5831